Literature DB >> 7858115

Cell cycle-associated autoantibodies: markers for autoimmunity and probes for molecular cell biology.

J P Yeo1, B H Toh.   

Abstract

Antinuclear autoantibodies are useful diagnostic markers for systemic autoimmune diseases and as probes for the molecular cell biology of nuclear proteins. Here, we review a subset of autoantibodies to nuclear and cytoplasmic proteins involved in the cell cycle. We propose a classification of these autoantibodies into S-phase (DNA Synthesis) and M-phase (Mitosis) autoantibodies. S-phase autoantibodies are represented by autoantibodies to PCNA (Proliferating Cell Nuclear Antigen), the auxiliary protein of DNA polymerase delta. M-phase autoantibodies are represented by autoantibodies to mitotic spindle components viz. centrosomes, condensed chromosomes, centromeres, mitotic spindle proper and intercellular bridge. We have included autoantibodies to nuclear lamins as M-phase autoantibodies as lamins play a key role in reversible breakdown and reformation of nuclear membranes during mitosis. The usefulness of these autoantibodies as diagnostic markers in systemic autoimmune disease is tempered by their presence in patients with "atypical" autoimmune diseases and in normal individuals. However, as molecular probes, they have proven to be unique and invaluable tools for shedding new light on the workings of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858115     DOI: 10.3109/08916939409009531

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  3 in total

1.  Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus.

Authors:  V M Gitlits; J W Sentry; M L Matthew; A I Smith; B H Toh
Journal:  Immunology       Date:  1997-11       Impact factor: 7.397

2.  Characterization of a cell cycle-dependent nuclear autoantigen.

Authors:  M Zuber
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

3.  Anti-PCNA autoantibodies preferentially recognize C-terminal of PCNA in patients with chronic hepatitis B virus infection.

Authors:  T-C Hsu; G J Tsay; T-Y Chen; Y-C Liu; B-S Tzang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.